|
Volumn 31, Issue 9, 2012, Pages 2147-2152
|
Clinical and epidemiological characteristics of adult patients hospitalized for erysipelas and cellulitis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACICLOVIR;
AMOXICILLIN PLUS CLAVULANIC ACID;
ANALGESIC AGENT;
ANTIBIOTIC AGENT;
AZITHROMYCIN;
BACITRACIN;
CEFOTAXIME;
CEFOXITIN;
CEFTRIAXONE;
CIPROFLOXACIN;
CLARITHROMYCIN;
CLINDAMYCIN;
CLOTRIMAZOLE;
CLOXACILLIN;
ERYTHROMYCIN;
IMIPENEM;
KETOCONAZOLE;
LINEZOLID;
MEROPENEM;
METRONIDAZOLE;
NEOMYCIN;
NYSTATIN;
PIPERACILLIN PLUS TAZOBACTAM;
POLYMYXIN B;
PSEUDOMONIC ACID;
SULFADIAZINE SILVER;
TERBINAFINE;
VANCOMYCIN;
ZINC SULFATE;
ABSCESS;
ADULT;
AGED;
ANTIBIOTIC THERAPY;
ARTICLE;
BLISTER;
CELLULITIS;
COMORBIDITY;
DIABETIC FOOT;
DISEASE SEVERITY;
DRUG RESPONSE;
DRUG SUBSTITUTION;
DRUG WITHDRAWAL;
EROSION;
ERYSIPELAS;
FEMALE;
HEMATOMA;
HOSPITAL PATIENT;
HUMAN;
INTERTRIGO;
LENGTH OF STAY;
MAJOR CLINICAL STUDY;
MALE;
MEDICAL RECORD REVIEW;
MYIASIS;
PRIORITY JOURNAL;
PROGNOSIS;
RETROSPECTIVE STUDY;
SEPSIS;
TERTIARY HEALTH CARE;
TINEA PEDIS;
UNSPECIFIED SIDE EFFECT;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTI-BACTERIAL AGENTS;
CELLULITIS;
COMORBIDITY;
ERYSIPELAS;
FEMALE;
HOSPITALIZATION;
HUMANS;
MALE;
MIDDLE AGED;
RETROSPECTIVE STUDIES;
SEVERITY OF ILLNESS INDEX;
SPAIN;
TERTIARY CARE CENTERS;
TREATMENT OUTCOME;
|
EID: 84866384209
PISSN: 09349723
EISSN: 14354373
Source Type: Journal
DOI: 10.1007/s10096-012-1549-2 Document Type: Article |
Times cited : (23)
|
References (9)
|